WHAT WE DO
We offer strategic support to companies during the drugs’ full lifecycle: from the regulatory process, including the Therapeutic Positioning Report (TPR) development to P&R submission, negotiation and approval, and Market Access at regional and hospital level. We do so by collaborating with relevant stakeholders, scientific societies and patients associations to ensure a successful Pricing and Market Access for innovative drugs in Spain.
OMAKASE LEADERSHIP TEAM
PUBLICATIONS
NEWS & EVENTS
-
Its now available the 4th edition of EDS Journal cotaining several articles about latest actuality. To highlight, there is an interesting entry about how to assess clinical benefit in order to accelerate access of innovative drugs where multidisciplinar experts have participatedIts now available the 4th edition of EDS Journal cotaining several articles about latest actuality. To highlight, there is an interesting entry about how to assess clinical benefit in order to accelerate access of innovative drugs where multidisciplinar experts have participated
-
Today at 1.30pm, Dr. Badía participates as an expert in the session “Cost, value and clinical benefit in the Oncology setting” to talk about MCDA for evaluating and positioning cancer treatments.Today at 1.30pm, Dr. Badía participates as an expert in the session “Cost, value and clinical benefit in the Oncology setting” to talk about MCDA for evaluating and positioning cancer treatments.
GET IN TOUCH
CONTACT INFO
BARCELONA & MADRID OFFICES
Telephone: +34 674614704 | +34 931890969
E-mail: administracion@omakaseconsulting.com
APPLY FOR A JOB
Please send your CV to: administracion@omakaseconsulting.com
Follow Us On Social Media!